Samuel N. Stroum was awarded E. Donnall Thomas Medal of Achievement Medal
In 1999, the Fred Hutchinson Business Alliance announced that the 1999 E. Donnall Thomas Medal of Achievement would…
Mouse model of prostate cancer was developed at Washington University – St Louis
On Dec. 22, 1998, Washington University – St. Louis researcher Jeffrey I. Gordon, MD and colleagues developed a…
Magnetic Surgery Tested Successfully on First Patient
Dec. 22, 1998, researchers from Barnes-Jewish Hospital in St. Louis announced using a revolutionary system that uses superconducting…
Lyme Disease Vaccine (Recombinant OspA) was licensed
On Dec. 21, 1998, the Lyme Disease Vaccine (Recombinant OspA), (LYMErix by SmithKline Beecham) was licensed for use…
University of California at Berkeley announced five-year, $25 million research partnership with Novartis
On Nov. 23, 1998, the University of California, Berkeley and the Novartis Agricultural Discovery Institute, announced they had…
Peter Eriksson and Fred Gage demonstrated that adult human brains make new neurons
On Oct. 30, 1998, Peter Eriksson of the Salk Institute and Fred Gage of the Sahlgrenska University Hospital…
Here’s the Beef: Japan Clones Adult Cows
On Oct. 8, 1998, a team from Kinki University reported the first successful cloning of adult cows. To…
The Fetal Alcohol Syndrome Surveillance Network was created
In Oct. 1998, the Fetal Alcohol Syndrome Surveillance Network was created to determine the prevalence of FAS within…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
The FDA approved the monoclonal antibody Herceptin (Trastuzumab) for treatment of metastatic breast cancer
On Sept. 25, 1998, the U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Herceptin (Trastuzumab) for…
Breast Cancer Prevention Trial Results published
On Sept. 14, 1998, researchers from the Breast Cancer Prevention Trial (BCPT) published a full report and update…
Medical College of Georgia researchers identified enzyme role in preventing a mother’s immune system from rejecting a fetus
On Sept. 8, 1998, the Medical College of Georgia researchers Dr. David Munn and immunologist Andrew Melllor identified…
Rotavirus vaccine, live, oral, tetravalent was licensed
On Aug. 31, 1998, Rotashield (Wyeth Laboratories, Marietta, Pennsylvania) was licensed by the U.S. Food and Drug Administration…
Bill and Melinda Gates Announce a $100 Million Gift to Establish the Bill and Melinda Gates Children’s Vaccine Program
On Aug. 26, 1998, Bill and Melinda Gates announced the establishment of the Bill and Melinda Gates Children’s Vaccine…
Biotechnology | Diagnostics | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health
The Stamp Out Breast Cancer stamp was first issued
On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Certiva by North American Vaccine) was licensed
On Jul. 29, 1998, the diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Certiva by North American…
Aptein was acquired by Cambridge Antibody Technology
On Jul. 15, 1998, Aptein, founded by Glenn Kawasaki in Seattle, was acquired by Cambridge Antibody Technology (CAT)…
Agriculture | Biotechnology | Genomics | USDA
GM papaya Seed resistant to the Ringspot-Virus were introduced
In 1998, Rainbow papaya seed, a transgenic virus-resistant variety, were released to farmers, allowing farmers to cultivate this…
The Seattle Cancer Care Alliance was formed
On Jun. 16, 1998, University of Washington Medicine, Fred Hutchinson Cancer Research Center and Seattle Children’s announced the…
Biotechnology | FDA | Oncology | Therapeutics
The FDA approved Genentech drug Xeloda (capecitabine)
On April 30, 1998, the U.S. Food and Drug Administration (FDA) approved the Genentech’s drug Xeloda (capecitabine) for…
The Stop TB Partnership was established
In March 1998, the Stop TB Initiative was established following a meeting of the First Ad hoc Committee…
National Donor Day was founded
On Feb. 14, 1998, National Donor Day was started by the Saturn Corporation and its United Auto Workers…
Seattle Genetics was incorporated
On Jan. 13, 1998, Seattle Genetics (Seagen) was founded in Bothell as a biotechnology company focused on developing…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The City of Hope Cancer Center received NCI comprehensive cancer center designation
In 1998, National Cancer Institute (NCI) awarded the City of Hope Cancer Center NCI-comprehensive cancer center designation. City…
The Neurological Sciences Institute joined OHSU as its fifth research unit
In 1998, the Neurological Sciences Institute (NSI) joined the university as its fifth research unit. NSI researchers conduct…
The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee
In 1998, The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee which…
Doernbecher Children’s Hospital’s new state-of-the-art pediatric medical complex was opened
In 1998, Doernbecher Children’s Hospital’s new state-of-the-art pediatric medical complex was opened. Built with private funding and bond…
Dr. Patrick Lee developed a reovirus that can infect and kill cancer cells without harming healthy cells
In 1998, University of Calgary’s Dr. Patrick Lee revealed that reovirus injected in mice shrank tumours from brain…
The Mark O Hatfield Research Center was dedicated
In 1998, The Mark O. Hatfield Research Center was dedicated. The center houses a variety of basic and…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
Cancer incidence rates showed first sustained decline since NCI began keeping records in 1973
In 1998, Cancer incidence rates showed first sustained decline since the National Cancer Institute (NCI) began keeping records…
Hematech relocated to Sioux Falls
In 1998, Hematech was co-founded by University of Massachusetts researcher Jim Robl, relocated to Sioux Falls. Dr. Robl…